Fatty Liver
Conditions
Brief summary
this is a prospective, interventional, open-label, randomized study on the efficacy of omega 3 fatty acids supplementation in Egyptian children with non-alcoholic fatty liver disease who had been selected from nutrition and outpatient clinic at Pediatric hospital, Ain Shams University
Interventions
DIETARY_SUPPLEMENTomega 3 fatty acids
: Life style modification, diet regimen and Omega-3 fatty acids supplementation: The dose of omega-3 fatty acids depended on the weight of patients according to World Health Organization recommendations 400 milligrams per 10 kilograms of body weight and had been given into two doses per day, before morning and evening meals
Sponsors
Ain Shams University
Study design
Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
6 Years to 16 Years
Healthy volunteers
No
Inclusion criteria
Children between 5 - 16 years old with diffusely hyper echogenic liver at ultrasonography were included in the study.
Exclusion criteria
* Patients with secondary causes of steatosis including total parenteral nutrition, drugs causing fatty liver disease for example steroids, hepatitis A, B, C, cytomegalovirus, Epstein-Barr virus infections, autoimmune liver disease, metabolic liver diseases, Wilson's disease, and alpha-1-antitrypsin deficiency. * Patients currently taking fish oil supplements. * Patients with systemic illness such as cardiac and kidney diseases.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| grade of fatty liver in children | 3 month | improvement |
Countries
Egypt
Outcome results
None listed